Skip to content

The effect of tourniquet application on the morphology and function of quadriceps in patients undergoing total knee arthroplasty: a prospective randomized controlled trial

The effect of tourniquet application on the morphology and function of quadriceps in patients undergoing total knee arthroplasty: a prospective randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035097
Enrollment
Unknown
Registered
2020-07-31
Start date
2020-08-03
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

No tourniquet group:don't use tourniquet

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Primary knee osteoarthritis was diagnosed by symptoms, physical examination and imaging examination, with X-ray K-L stage III or above; (2) With severe knee pain, limited function and ineffective conservative treatment, unilateral primary knee replacement was planned; (3) No severe varus or valgus of knee joint (< 20 degrees).

Exclusion criteria

Exclusion criteria: (1) Previous long-term use of anticoagulant drugs for cardiovascular and cerebrovascular diseases for more than 3 months without stopping (aspirin/clopidogrel = 25.3mmol/L or blood creatinine >= 442umol/L), liver insufficiency (ALT or AST >= 80U/L), severe heart disease (or coronary stent implantation in the last 12 months), severe respiratory diseases (pulmonary function FEV1.0 = 46 seconds or INR >= 1.7)or history of stroke and malignant tumor. (2) Refusing to sign the informed consent form for not accepting this trial for any reason.

Design outcomes

Primary

MeasureTime frame
Thickness of quadriceps;Hardness of quadriceps;Thigh circumference;HSS (Hospital of Special Surgery Score) and WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index);total blood loss;Visual analogue scale;Isokinetic strength;Three-dimensional gait;Balance posture;hemoglobin;hematocrit;C-Reactive Protein;D-Dimer;operating time;

Secondary

MeasureTime frame
time of using tourniquet;

Countries

China

Contacts

Public ContactYang Li

Peking University Third Hospital

liyangdr@bjmu.edu.cn+86 13810634362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026